{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T20:45:58Z","timestamp":1791751558773,"version":"4.3.4"},"reference-count":101,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microvascular Research"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.mvr.2007.04.009","type":"journal-article","created":{"date-parts":[[2007,5,9]],"date-time":"2007-05-09T07:04:39Z","timestamp":1178694279000},"page":"1-8","source":"Crossref","is-referenced-by-count":222,"title":["Molecular mechanisms of preeclampsia"],"prefix":"10.1016","volume":"75","author":[{"given":"Walter P.","family":"Mutter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Ananth","family":"Karumanchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mvr.2007.04.009_bib1","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.ajog.2006.06.089","article-title":"Preeclampsia and subsequent risk of cancer in Utah","volume":"195","author":"Aagaard-Tillery","year":"2006","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.mvr.2007.04.009_bib2","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/nm0901-1003","article-title":"Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness","volume":"7","author":"AbdAlla","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.mvr.2007.04.009_bib3","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1161\/01.RES.0000147365.86159.f5","article-title":"Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia","volume":"95","author":"Ahmad","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.mvr.2007.04.009_bib4","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/08977199509036883","article-title":"Colocalisation of vascular endothelial growth factor and its Flt-1 receptor in human placenta","volume":"12","author":"Ahmed","year":"1995","journal-title":"Growth Factors"},{"issue":"Suppl A","key":"10.1016\/j.mvr.2007.04.009_bib5","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1053\/plac.1999.0524","article-title":"Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (PIGF) and soluble Flt-1 by oxygen\u2014a review","volume":"21","author":"Ahmed","year":"2000","journal-title":"Placenta"},{"key":"10.1016\/j.mvr.2007.04.009_bib6","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1161\/01.HYP.27.1.56","article-title":"Plasma of preeclamptic women stimulates and then inhibits endothelial prostacyclin","volume":"27","author":"Baker","year":"1996","journal-title":"Hypertension"},{"key":"10.1016\/j.mvr.2007.04.009_bib7","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1111\/j.1523-1755.2005.00260.x","article-title":"Glomerular endothelial cell differentiation","volume":"67","author":"Ballermann","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.mvr.2007.04.009_bib8","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1210\/jc.86.6.2505","article-title":"Expression of inflammatory cytokines in placentas from women with preeclampsia","volume":"86","author":"Benyo","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mvr.2007.04.009_bib9","first-page":"177","article-title":"The role of the spiral arteries in the pathogenesis of preeclampsia","volume":"1","author":"Brosens","year":"1972","journal-title":"Obstet. Gynecol. Annu."},{"issue":"Suppl A","key":"10.1016\/j.mvr.2007.04.009_bib10","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1053\/plac.1999.0522","article-title":"Oxygen and placental development during the first trimester: implications for the pathophysiology of pre-eclampsia","volume":"21","author":"Caniggia","year":"2000","journal-title":"Placenta"},{"key":"10.1016\/j.mvr.2007.04.009_bib11","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.ajog.2004.03.043","article-title":"Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award","volume":"190","author":"Chaiworapongsa","year":"2004","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.mvr.2007.04.009_bib12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/14767050400028816","article-title":"Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia","volume":"17","author":"Chaiworapongsa","year":"2005","journal-title":"J. Matern. Fetal Neonatal. Med."},{"key":"10.1016\/j.mvr.2007.04.009_bib13","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1001\/jama.285.12.1607","article-title":"Association of maternal endothelial dysfunction with preeclampsia","volume":"285","author":"Chambers","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.mvr.2007.04.009_bib14","doi-asserted-by":"crossref","first-page":"19027","DOI":"10.1016\/S0021-9258(18)41732-2","article-title":"Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells","volume":"267","author":"Cheifetz","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mvr.2007.04.009_bib15","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/0002-9378(65)90462-X","article-title":"Vascular reactivity to angiotensin II and norepinephrine in pregnant women","volume":"91","author":"Chesley","year":"1965","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.mvr.2007.04.009_bib16","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/0002-9378(92)91372-H","article-title":"Plasma endothelin levels in preeclampsia: elevation and correlation with uric acid levels and renal impairment","volume":"166","author":"Clark","year":"1992","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.mvr.2007.04.009_bib17","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1161\/01.HYP.30.2.247","article-title":"Flow-mediated vasodilatation is enhanced in normal pregnancy but reduced in preeclampsia","volume":"30","author":"Cockell","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.mvr.2007.04.009_bib18","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1093\/jnci\/93.15.1133","article-title":"Placental characteristics and reduced risk of maternal breast cancer","volume":"93","author":"Cohn","year":"2001","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.mvr.2007.04.009_bib19","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1600-0897.1998.tb00398.x","article-title":"Circulating levels of immunoreactive cytokines in women with preeclampsia","volume":"40","author":"Conrad","year":"1998","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.mvr.2007.04.009_bib20","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1126\/science.7985020","article-title":"Implantation and the placenta: key pieces of the development puzzle","volume":"266","author":"Cross","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.mvr.2007.04.009_bib21","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1161\/CIRCULATIONAHA.106.660134","article-title":"Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1","volume":"115","author":"Cudmore","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.mvr.2007.04.009_bib22","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0955-0674(98)80043-4","article-title":"Trophoblast pseudo-vasculogenesis: faking it with endothelial adhesion receptors","volume":"10","author":"Damsky","year":"1998","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.mvr.2007.04.009_bib23","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1055\/s-2007-1016254","article-title":"Oxidative stress and altered endothelial cell function in preeclampsia","volume":"16","author":"Davidge","year":"1998","journal-title":"Semin. Reprod. Endocrinol."},{"key":"10.1016\/j.mvr.2007.04.009_bib25","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1161\/01.CIR.101.20.2382","article-title":"AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor","volume":"101","author":"Dechend","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.mvr.2007.04.009_bib24","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1161\/01.HYP.0000154785.50570.63","article-title":"Agonistic autoantibodies to the AT1 receptor in a transgenic rat model of preeclampsia","volume":"45","author":"Dechend","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.mvr.2007.04.009_bib26","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000146886","article-title":"Fetal vasculogenesis and angiogenesis in human placental villi","volume":"136","author":"Demir","year":"1989","journal-title":"Acta Anat. (Basel)"},{"key":"10.1016\/j.mvr.2007.04.009_bib27","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1016\/S0002-9440(10)65089-4","article-title":"Angiopoietin-1 and angiopoietin-2 activate trophoblast Tie-2 to promote growth and migration during placental development","volume":"156","author":"Dunk","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.mvr.2007.04.009_bib28","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1067\/S0002-9378(03)00661-6","article-title":"Adverse pregnancy outcomes in snuff users","volume":"189","author":"England","year":"2003","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.mvr.2007.04.009_bib29","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1172\/JCI17423","article-title":"Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases","volume":"111","author":"Eremina","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mvr.2007.04.009_bib30","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1056\/NEJM199111143252009","article-title":"Pregnancy, preeclampsia, and the endothelial cell","volume":"325","author":"Ferris","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mvr.2007.04.009_bib31","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1128\/MCB.16.9.4604","article-title":"Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1","volume":"16","author":"Forsythe","year":"1996","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.mvr.2007.04.009_bib32","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/0002-9378(95)90113-2","article-title":"Biochemical corroboration of endothelial involvement in severe preeclampsia","volume":"172","author":"Friedman","year":"1995","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.mvr.2007.04.009_bib33","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1172\/JCI107462","article-title":"A study of angiotensin II pressor response throughout primigravid pregnancy","volume":"52","author":"Gant","year":"1973","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mvr.2007.04.009_bib34","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0272-6386(87)80126-9","article-title":"Control of vascular reactivity in pregnancy","volume":"9","author":"Gant","year":"1987","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.mvr.2007.04.009_bib35","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1126\/science.277.5332.1669","article-title":"Regulation of human placental development by oxygen tension","volume":"277","author":"Genbacev","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.mvr.2007.04.009_bib36","doi-asserted-by":"crossref","first-page":"23659","DOI":"10.1074\/jbc.272.38.23659","article-title":"Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1\/KDR, is up-regulated by hypoxia","volume":"272","author":"Gerber","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mvr.2007.04.009_bib37","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1161\/01.HYP.0000251522.18094.d4","article-title":"Endothelial dysfunction: a link among preeclampsia, recurrent pregnancy loss, and future cardiovascular events?","volume":"49","author":"Germain","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.mvr.2007.04.009_bib38","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1210\/jc.2002-020195","article-title":"Human placental vascular development: vasculogenic and angiogenic (branching and nonbranching) transformation is regulated by vascular endothelial growth factor-A, angiopoietin-1, and angiopoietin-2","volume":"87","author":"Geva","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mvr.2007.04.009_bib39","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/molehr\/6.1.81","article-title":"Tie-2 and angiopoietin-2 expression at the fetal-maternal interface: a receptor ligand model for vascular remodelling","volume":"6","author":"Goldman-Wohl","year":"2000","journal-title":"Mol. Hum. Reprod."},{"key":"10.1016\/j.mvr.2007.04.009_bib40","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/intimm\/4.1.83","article-title":"Identification of distinct epitopes of endoglin, an RGD-containing glycoprotein of endothelial cells, leukemic cells, and syncytiotrophoblasts","volume":"4","author":"Gougos","year":"1992","journal-title":"Int. Immunol."},{"key":"10.1016\/j.mvr.2007.04.009_bib41","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1210\/me.13.4.537","article-title":"Alternative splicing of vascular endothelial growth factor (VEGF)-R1 (FLT-1) pre-mRNA is important for the regulation of VEGF activity","volume":"13","author":"He","year":"1999","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mvr.2007.04.009_bib42","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1373\/clinchem.2004.036715","article-title":"Maternal serum sFlt1 concentration is an early and reliable predictive marker of preeclampsia","volume":"50","author":"Hertig","year":"2004","journal-title":"Clin. Chem."},{"key":"10.1016\/j.mvr.2007.04.009_bib43","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0002-9378(93)90151-8","article-title":"Elevated circulating thrombomodulin in severe preeclampsia","volume":"169","author":"Hsu","year":"1993","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.mvr.2007.04.009_bib44","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0002-9378(96)70336-8","article-title":"Fasting serum triglycerides, free fatty acids, and malondialdehyde are increased in preeclampsia, are positively correlated, and decrease within 48\u00a0hours post partum","volume":"174","author":"Hubel","year":"1996","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.mvr.2007.04.009_bib45","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1136\/bmj.323.7323.1213","article-title":"Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study","volume":"323","author":"Irgens","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.mvr.2007.04.009_bib46","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1200\/JCO.2003.10.066","article-title":"Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)\/leucovorin (LV) with FU\/LV alone in patients with metastatic colorectal cancer","volume":"21","author":"Kabbinavar","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.mvr.2007.04.009_bib47","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/BF00316301","article-title":"The fetal vascularisation of term human placental villi: II. Intermediate and terminal villi","volume":"173","author":"Kaufmann","year":"1985","journal-title":"Anat. Embryol. (Berl)"},{"key":"10.1016\/j.mvr.2007.04.009_bib48","doi-asserted-by":"crossref","first-page":"10705","DOI":"10.1073\/pnas.90.22.10705","article-title":"Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor","volume":"90","author":"Kendall","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mvr.2007.04.009_bib49","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1006\/bbrc.1996.1355","article-title":"Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR","volume":"226","author":"Kendall","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mvr.2007.04.009_bib50","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1620\/tjem.195.43","article-title":"Glomerular endothelial cells are maintained by vascular endothelial growth factor in the adult kidney","volume":"195","author":"Kitamoto","year":"2001","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.mvr.2007.04.009_bib51","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1210\/jc.2002-021942","article-title":"Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia","volume":"88","author":"Koga","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"Suppl 1","key":"10.1016\/j.mvr.2007.04.009_bib52","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000272583","article-title":"Measuring the concentration of various plasma and placenta extract proteolytic and vascular factors in pregnant patients with HELLP syndrome, pre-\/eclampsia and highly pathologic Doppler flow values","volume":"35","author":"Kolben","year":"1995","journal-title":"Gynakol. Geburtshilfliche Rundsch."},{"key":"10.1016\/j.mvr.2007.04.009_bib53","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0301-2115(96)02484-0","article-title":"Proteases and their inhibitors are indicative in gestational disease","volume":"68","author":"Kolben","year":"1996","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.mvr.2007.04.009_bib54","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1172\/JCI115367","article-title":"Hypoxia induces endothelin gene expression and secretion in cultured human endothelium","volume":"88","author":"Kourembanas","year":"1991","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mvr.2007.04.009_bib55","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1161\/01.ATV.0000030186.66672.36","article-title":"Analysis of coagulation cascade and endothelial cell activation during inhibition of vascular endothelial growth factor\/vascular endothelial growth factor receptor pathway in cancer patients","volume":"22","author":"Kuenen","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.mvr.2007.04.009_bib56","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF00707305","article-title":"The fetal vascularisation of term human placental villi. I. Peripheral stem villi","volume":"173","author":"Leiser","year":"1985","journal-title":"Anat. Embryol. (Berl)"},{"key":"10.1016\/j.mvr.2007.04.009_bib58","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mvr.2007.04.009_bib59","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1001\/jama.293.1.77","article-title":"Urinary placental growth factor and risk of preeclampsia","volume":"293","author":"Levine","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.mvr.2007.04.009_bib57","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJMoa055352","article-title":"Soluble endoglin and other circulating antiangiogenic factors in preeclampsia","volume":"355","author":"Levine","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mvr.2007.04.009_bib60","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3109\/00365518409085374","article-title":"Uteroplacental blood flow in pregnancy induced hypertension","volume":"169","author":"Lunell","year":"1984","journal-title":"Scand. J. Clin. Lab. Invest., Suppl."},{"key":"10.1016\/j.mvr.2007.04.009_bib61","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2353\/ajpath.2006.050834","article-title":"Vascular endothelial growth factor localization in the adult","volume":"168","author":"Maharaj","year":"2006","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.mvr.2007.04.009_bib62","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/sj.ki.5002175","article-title":"Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1","volume":"71","author":"Makris","year":"2007","journal-title":"Kidney Int."},{"key":"10.1016\/j.mvr.2007.04.009_bib63","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mvr.2007.04.009_bib64","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/0002-9378(93)90389-Z","article-title":"Abnormal endothelial cell function of resistance arteries from women with preeclampsia","volume":"168","author":"McCarthy","year":"1993","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.mvr.2007.04.009_bib65","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.ajog.2004.03.004","article-title":"Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop","volume":"191","author":"McKeeman","year":"2004","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.mvr.2007.04.009_bib66","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1001\/jama.282.4.356","article-title":"Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study","volume":"282","author":"Mills","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.mvr.2007.04.009_bib67","doi-asserted-by":"crossref","first-page":"4838","DOI":"10.1210\/en.2004-0533","article-title":"Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia","volume":"145","author":"Nagamatsu","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.mvr.2007.04.009_bib68","doi-asserted-by":"crossref","first-page":"R1085","DOI":"10.1152\/ajpregu.00794.2005","article-title":"Increased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-1","volume":"291","author":"Nevo","year":"2006","journal-title":"Am. J. Physiol., Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.mvr.2007.04.009_bib69","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/35015579","article-title":"Excessive placental secretion of neurokinin B during the third trimester causes pre-eclampsia","volume":"405","author":"Page","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.mvr.2007.04.009_bib70","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1136\/bmj.38032.820451.7C","article-title":"Cancer after pre-eclampsia: follow up of the Jerusalem perinatal study cohort","volume":"328","author":"Paltiel","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.mvr.2007.04.009_bib71","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/biolreprod\/64.2.499","article-title":"Selective overexpression of the hypoxia-inducible transcription factor, HIF-2alpha, in placentas from women with preeclampsia","volume":"64","author":"Rajakumar","year":"2001","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.mvr.2007.04.009_bib72","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1053\/plac.2002.0893","article-title":"Impaired oxygen-dependent reduction of HIF-1alpha and-2alpha proteins in pre-eclamptic placentae","volume":"24","author":"Rajakumar","year":"2003","journal-title":"Placenta"},{"key":"10.1016\/j.mvr.2007.04.009_bib73","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/S0140-6736(05)67726-4","article-title":"Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study","volume":"366","author":"Ray","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.mvr.2007.04.009_bib74","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/s-2007-1016248","article-title":"Endothelial dysfunction in preeclampsia","volume":"16","author":"Roberts","year":"1998","journal-title":"Semin. Reprod. Endocrinol."},{"key":"10.1016\/j.mvr.2007.04.009_bib75","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(00)03577-7","article-title":"Pathogenesis and genetics of pre-eclampsia","volume":"357","author":"Roberts","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.mvr.2007.04.009_bib76","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/0002-9378(89)90665-0","article-title":"Preeclampsia: an endothelial cell disorder","volume":"161","author":"Roberts","year":"1989","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.mvr.2007.04.009_bib77","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S1521-6934(03)00008-7","article-title":"Pre-eclampsia and thrombophilia","volume":"17","author":"Said","year":"2003","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"10.1016\/j.mvr.2007.04.009_bib78","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0140-6736(03)13177-7","article-title":"Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia","volume":"361","author":"Savvidou","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.mvr.2007.04.009_bib79","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1056\/NEJM199611143352002","article-title":"Preeclampsia\u2014a state of sympathetic overactivity","volume":"335","author":"Schobel","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mvr.2007.04.009_bib80","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.1210\/jc.2004-1955","article-title":"Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor","volume":"90","author":"Shibata","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mvr.2007.04.009_bib81","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/359843a0","article-title":"Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis","volume":"359","author":"Shweiki","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.mvr.2007.04.009_bib82","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0146-0005(03)00022-3","article-title":"What we have learned about preeclampsia","volume":"27","author":"Sibai","year":"2003","journal-title":"Semin. Perinatol."},{"key":"10.1016\/j.mvr.2007.04.009_bib83","doi-asserted-by":"crossref","first-page":"12605","DOI":"10.1074\/jbc.C300012200","article-title":"Neutralization of circulating vascular endothelial growth factor (VEGF\/) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria","volume":"278","author":"Sugimoto","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mvr.2007.04.009_bib84","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/0002-9378(91)90435-T","article-title":"High plasma cellular fibronectin levels correlate with biochemical and clinical features of preeclampsia but cannot be attributed to hypertension alone","volume":"165","author":"Taylor","year":"1991","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.mvr.2007.04.009_bib86","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0029-7844(99)00400-7","article-title":"High body mass index and hypercholesterolemia: risk of hypertensive disorders of pregnancy","volume":"94","author":"Thadhani","year":"1999","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.mvr.2007.04.009_bib85","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1161\/01.HYP.0000124460.67539.1d","article-title":"Insulin resistance and alterations in angiogenesis: additive insults that may lead to preeclampsia","volume":"43","author":"Thadhani","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.mvr.2007.04.009_bib87","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1161\/01.RES.0000159936.38601.22","article-title":"A role for endoglin in coupling eNOS activity and regulating vascular tone revealed in hereditary hemorrhagic telangiectasia","volume":"96","author":"Toporsian","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.mvr.2007.04.009_bib88","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/sj.bjc.6600581","article-title":"Pre-eclampsia in pregnancy and subsequent risk for breast cancer","volume":"87","author":"Vatten","year":"2002","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.mvr.2007.04.009_bib89","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nm1429","article-title":"Soluble endoglin contributes to the pathogenesis of preeclampsia","volume":"12","author":"Venkatesha","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.mvr.2007.04.009_bib90","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/S0140-6736(00)02800-2","article-title":"Pre-eclampsia","volume":"356","author":"Walker","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.mvr.2007.04.009_bib91","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1172\/JCI4106","article-title":"Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor","volume":"103","author":"Wallukat","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mvr.2007.04.009_bib92","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/01.AOG.0000249609.04831.7c","article-title":"Mapping the theories of preeclampsia and the role of angiogenic factors: a systematic review","volume":"109","author":"Widmer","year":"2007","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.mvr.2007.04.009_bib93","first-page":"H748","article-title":"Nitric oxide-mediated vasodilation in human pregnancy","volume":"272","author":"Williams","year":"1997","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.mvr.2007.04.009_bib94","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0029-7844(01)01551-4","article-title":"Obesity and preeclampsia: the potential role of inflammation","volume":"98","author":"Wolf","year":"2001","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.mvr.2007.04.009_bib95","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1210\/jc.87.4.1563","article-title":"First trimester insulin resistance and subsequent preeclampsia: a prospective study","volume":"87","author":"Wolf","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mvr.2007.04.009_bib96","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa021491","article-title":"A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer","volume":"349","author":"Yang","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mvr.2007.04.009_bib97","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1081\/PRG-120021066","article-title":"Severe maternal morbidity associated with hypertensive disorders in pregnancy in the United States","volume":"22","author":"Zhang","year":"2003","journal-title":"Hypertens. Pregnancy"},{"key":"10.1016\/j.mvr.2007.04.009_bib98","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1172\/JCI119388","article-title":"Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome?","volume":"99","author":"Zhou","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mvr.2007.04.009_bib99","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1172\/JCI119387","article-title":"Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion?","volume":"99","author":"Zhou","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mvr.2007.04.009_bib100","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0012-1606(03)00449-4","article-title":"Human cytotrophoblasts promote endothelial survival and vascular remodeling through secretion of Ang2, PlGF, and VEGF-C","volume":"263","author":"Zhou","year":"2003","journal-title":"Dev. Biol."},{"key":"10.1016\/j.mvr.2007.04.009_bib101","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1749-6632.2003.tb03211.x","article-title":"The human placenta remodels the uterus by using a combination of molecules that govern vasculogenesis or leukocyte extravasation","volume":"995","author":"Zhou","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."}],"container-title":["Microvascular Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002628620700057X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002628620700057X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T02:40:31Z","timestamp":1628822431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002628620700057X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":101,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S002628620700057X"],"URL":"https:\/\/doi.org\/10.1016\/j.mvr.2007.04.009","relation":{},"ISSN":["0026-2862"],"issn-type":[{"value":"0026-2862","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}